October 8, 2025 · Form 4 insider transaction
Scadden David sold 200 shares of Agios Pharmaceuticals, Inc. at $41.00 per share, a transaction worth $8.2K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.